APA (7th ed.) Citation

Lombardo, M., Maccauro, C., D’Ambrosio, M., Grossi, M., Missiroli, F., Cesareo, M., & Ricci, F. (2025, October). Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: A retrospective OCT-angiography study. International Journal of Retina and Vitreous.

Chicago Style (17th ed.) Citation

Lombardo, Marco, Carlo Maccauro, Michele D’Ambrosio, Massimo Grossi, Filippo Missiroli, Massimo Cesareo, and Federico Ricci. "Aflibercept, Ranibizumab, and Bevacizumab for Macular Neovascularization Secondary to Age-related Macular Degeneration: A Retrospective OCT-angiography Study." International Journal of Retina and Vitreous Oct. 2025.

MLA (9th ed.) Citation

Lombardo, Marco, et al. "Aflibercept, Ranibizumab, and Bevacizumab for Macular Neovascularization Secondary to Age-related Macular Degeneration: A Retrospective OCT-angiography Study." International Journal of Retina and Vitreous, Oct. 2025.